Creutzfeldt-Jakob disease.

[1]  L. Pani,et al.  Management of notifications of donors with Creutzfeldt-Jakob disease (post-donation information). , 2014, Blood transfusion = Trasfusione del sangue.

[2]  P. Panegyres,et al.  Therapies for human prion diseases. , 2013, American journal of neurodegenerative disease.

[3]  S. Sullivan,et al.  Iatrogenic Creutzfeldt-Jakob disease via surgical instruments , 2013, Journal of Clinical Neuroscience.

[4]  B. Ances,et al.  Diagnosis and evaluation of a patient with rapidly progressive dementia. , 2013, Missouri medicine.

[5]  J. Collinge,et al.  Genetics of prion diseases , 2013, Current opinion in genetics & development.

[6]  K. Masaki,et al.  Creutzfeldt-Jakob disease: a case report and differential diagnoses. , 2013, Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health.

[7]  A. Araujo.  Prionic diseases. , 2013, Arquivos de neuro-psiquiatria.

[8]  C. V. van Duijn,et al.  Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  C. Lyketsos,et al.  Rapidly progressive dementias and the treatment of human prion diseases , 2011, Expert opinion on pharmacotherapy.

[10]  S. Love,et al.  Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  Peter Rudge,et al.  Variant CJD in an individual heterozygous for PRNP codon 129 , 2009, The Lancet.

[12]  J. Ironside,et al.  A case of protease sensitive prionopathy in a patient in the UK , 2009, Neuropathology and applied neurobiology.

[13]  J. Langeveld,et al.  Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. , 2009, Brain : a journal of neurology.

[14]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[15]  B. Ghetti,et al.  Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification , 2009, Acta Neuropathologica.

[16]  D. Galanaud,et al.  MRI lesion profiles in sporadic Creutzfeldt–Jakob disease , 2009, Neurology.

[17]  J. Ironside,et al.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey , 2009, BMJ : British Medical Journal.

[18]  T. Montine,et al.  A novel human disease with abnormal prion protein sensitive to protease , 2008, Annals of neurology.

[19]  J. Collinge,et al.  A systematic review of prion therapeutics in experimental models. , 2006, Brain : a journal of neurology.

[20]  P. Brown,et al.  Iatrogenic Creutzfeldt–Jakob disease , 2006, Neurology.

[21]  James W Ironside,et al.  Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study , 2006, BMJ : British Medical Journal.

[22]  M. Yamada.  The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram , 2006, The Lancet.

[23]  J. Ironside,et al.  Variant Creutzfeldt–Jakob disease: risk of transmission by blood transfusion and blood therapies , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  Dawn Everington,et al.  Risk factors for variant Creutzfeldt–Jakob disease: A case–control study , 2006, Annals of neurology.

[25]  A. Aguzzi,et al.  Genetic prion disease: the EUROCJD experience , 2005, Human Genetics.

[26]  R. Will,et al.  Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the “Heidenhain variant” , 2005, British Journal of Ophthalmology.

[27]  Lorraine C. Smith,et al.  Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein , 2004, The Lancet.

[28]  A. Aguzzi,et al.  Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. , 2004, Brain : a journal of neurology.

[29]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[30]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[31]  E. Granieri,et al.  Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases , 2004, Neurological Sciences.

[32]  J. Ironside,et al.  Prion protein heterogeneity in sporadic but not variant Creutzfeldt–Jakob disease: U.K. cases 1991–2002 , 2004, Annals of neurology.

[33]  W. Nailon,et al.  Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. , 2004, The American journal of pathology.

[34]  S. Cousens,et al.  The epidemiology of variant Creutzfeldt-Jakob disease. , 2004, Current topics in microbiology and immunology.

[35]  R. Will,et al.  Clinical features of variant Creutzfeldt-Jakob disease. , 2004, Current topics in microbiology and immunology.

[36]  A. Aguzzi,et al.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[37]  S. Tabrizi,et al.  Ethical issues in human prion diseases. , 2003, British medical bulletin.

[38]  H. Budka,et al.  Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.

[39]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[40]  H. Budka.  Neuropathology of prion diseases. , 2003, British medical bulletin.

[41]  H. Budka,et al.  Disease-associated prion protein in vessel walls. , 2002, The American journal of pathology.

[42]  H. Budka,et al.  Mutations of the Prion Protein Gene , 2002, Journal of Neurology.

[43]  R. Will,et al.  First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features , 2002, BMJ : British Medical Journal.

[44]  M. Zeidler,et al.  Sensory features of variant Creutzfeldt-Jakob disease , 2002, Journal of Neurology.

[45]  A. Green,et al.  14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt–Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein , 2002, Neuroscience Letters.

[46]  J. Ironside,et al.  Pathological diagnosis of variant Creutzfeldt‐Jakob disease , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[47]  A. Colchester,et al.  MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. , 2001, Clinical radiology.

[48]  J. Ironside,et al.  Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues , 2001, The Lancet.

[49]  L. McShane,et al.  Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2000, Neurology.

[50]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[51]  H. Budka,et al.  Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies , 1999, Acta Neuropathologica.

[52]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[53]  S. Chin,et al.  A subtype of sporadic prion disease mimicking fatal familial insomnia , 1999, Neurology.

[54]  S. Prusiner,et al.  Prion protein conformation in a patient with sporadic fatal insomnia. , 1999, The New England journal of medicine.

[55]  T. Sato,et al.  Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. , 1999, Archives of neurology.

[56]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[57]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[58]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[59]  H. Budka,et al.  Distribution of Parvalbumin‐Immunoreactive Neurons in Brain Correlates with Hippocampal and Temporal Cortical Pathology in Creutzfeldt‐Jakob Disease , 1997, Journal of neuropathology and experimental neurology.

[60]  M. Zeidler,et al.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests , 1997, The Lancet.

[61]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[62]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[63]  R. Will,et al.  Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.

[64]  P. Daniel,et al.  Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee , 1968, Science.

[65]  H. Creutzfeldt.  Über eine eigenartige herdförmige erkrankung des zentralnervensystems (Vorläufige mitteilung) , 1920 .